AlphaVest Acquisition Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
David Yan
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 2.8yrs |
Recent management updates
No updates
Recent updates
CEO
David Yan (52 yo)
no data
Tenure
Mr. Yong Yan, also known as David, PhD, serves as an Independent Director of Curanex Pharmaceuticals Inc since June 2024. He joined Curanex Pharmaceuticals Inc in June 2024. Heis CEO & Director of AlphaVes...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | no data | no data | no data | |
| Independent Director | 2.8yrs | no data | no data | |
| Independent Director | 2.8yrs | no data | no data | |
| Chairman of the Board | no data | no data | 22.01% $ 17.3m | |
| Independent Director | less than a year | no data | no data |
2.8yrs
Average Tenure
39yo
Average Age
Experienced Board: ATMV's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.